These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10797830)

  • 1. [Chronic cardiac insufficiency. Treatment with angiotensin I converting enzyme inhibitors and angiotensin II receptor antagonists].
    Juilliére Y; Berder V
    Presse Med; 2000 Apr; 29(13):743-8. PubMed ID: 10797830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism.
    Brunner-La Rocca HP; Vaddadi G; Esler MD
    J Am Coll Cardiol; 1999 Apr; 33(5):1163-73. PubMed ID: 10193712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects.
    Regitz-Zagrosek V; Neuss M; Fleck E
    Eur Heart J; 1995 Dec; 16 Suppl N():86-91. PubMed ID: 8682068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II Type 1 receptor antagonists in chronic heart failure.
    Thürmann PA; Collette D
    Expert Opin Investig Drugs; 2002 May; 11(5):705-16. PubMed ID: 11996651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of angiotensin II receptor antagonists as a novel drug for the treatment of chronic heart failure--in comparison with ACE inhibitors].
    Kitakaze M; Kuzuya T; Hori M
    Nihon Rinsho; 1999 May; 57(5):1148-57. PubMed ID: 10361449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of inhibitors of angiotensin-converting enzyme combined with antagonists of angiotensin II receptors on endothelial function in patients with chronic cardiac insufficiency].
    Korzh AN; Bondarenko TI; Raĭnina IV
    Lik Sprava; 2001; (2):33-6. PubMed ID: 11519426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure and angiotensin converting enzyme inhibition: problems and perspectives.
    Simko F; Simko J
    Physiol Res; 1999; 48(1):1-8. PubMed ID: 10470860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiological function of angiotensin II AT1 and AT2 receptors and clinical application of AT1 antagonists].
    Matsubara H; Mori Y; Masaki H; Inada M
    Nihon Rinsho; 1998 Jul; 56(7):1912-8. PubMed ID: 9702075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AT1 angiotensin receptor inhibition as a new therapeutic possibility].
    Hunyady L; Nagy L
    Orv Hetil; 1997 Oct; 138(41):2583-90. PubMed ID: 9411327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the renin-angiotensin system.
    Cheung BM
    Hong Kong Med J; 2002 Jun; 8(3):185-91. PubMed ID: 12055364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
    Sanada S; Kitakaze M
    Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE; McKinnie JJ; Greenberg SS; Giles TD
    Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin II antagonists in the treatment of cardiac decompensation].
    Gerc V; Buksa M
    Med Arh; 2003; 57(2):109-14. PubMed ID: 12822385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of angiotensin II-receptor antagonists.
    Pitt B; Konstam MA
    Am J Cardiol; 1998 Nov; 82(10A):47S-49S. PubMed ID: 9860359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Unexpected properties of angiotensin mediated by the AT2 receptor: possible therapeutic implications].
    Kostowski W
    Pol Merkur Lekarski; 2003 Feb; 14(80):99-101. PubMed ID: 12728664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.